The American Journal of Managed Care: FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder Medical Xpress: New study redefines how antidepressants aid in treating major depressive disorder Researchers from the University of Colorado Anschutz Medical Campus have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD), ... FiercePharma: J&J's Caplyta supersizes its reach with FDA nod as add-on treatment for major depressive disorder J&J's Caplyta supersizes its reach with FDA nod as add-on treatment for major depressive disorder Healio: Major depressive disorder linked to worse asthma outcomes among older adults Please provide your email address to receive an email when new articles are posted on . Among 336 patients with asthma, 46 also had major depressive disorder.
There were longitudinal associations ... PsyPost on MSN: Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder Major Depressive Disorder (MDD) is increasingly recognised not solely as an affective disorder but also as one characterised by enduring cognitive impairments. These deficits, affecting domains such ...
